Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH Fibrosis”

315 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 315 results

Not applicableUnknownNCT05486767
What this trial is testing

Screening of Liver Fibrosis in Adults Without Known Liver Disease

Who this might be right for
Liver Fibrosis
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica 1,000
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Not applicableNot Yet RecruitingNCT06739486
What this trial is testing

Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic Fibrosis+1 more
Assiut University 100
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Testing effectiveness (Phase 2)Study completedNCT04321031
What this trial is testing

Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis With Liver Fibrosis
Pfizer 256
Not applicableStudy completedNCT02083367
What this trial is testing

Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome

Who this might be right for
Hepatic EncephalopathyCirrhosisNonalcoholic Steatohepatitis+1 more
OSF Healthcare System 12
Not applicableLooking for participantsNCT04442334
What this trial is testing

The European NAFLD Registry

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+9 more
Newcastle University 10,000
Not applicableLooking for participantsNCT06814600
What this trial is testing

Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients

Who this might be right for
NAFLDInflammatory Bowel DiseasesSteatosis+1 more
Centre Hospitalier Universitaire Saint Pierre 150
Not applicableUnknownNCT04057287
What this trial is testing

Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC)

Who this might be right for
Liver Cirrhoses
Institute of Liver and Biliary Sciences, India 670
Not applicableActive Not RecruitingNCT05479721
What this trial is testing

LITMUS Imaging Study

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+2 more
University of Oxford 450
Very early researchStudy completedNCT05737433
What this trial is testing

Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects

Who this might be right for
NASH With Fibrosis
Hepion Pharmaceuticals, Inc. 6
Not applicableStudy completedNCT03753438
What this trial is testing

Intragastric Balloon in Compensated NASH(Non Alcoholic Steato Hepatitis) Cirrhotics

Who this might be right for
Liver Cirrhosis
Institute of Liver and Biliary Sciences, India 56
Large-scale testing (Phase 3)Ended earlyNCT03053050
What this trial is testing

Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 808
Early research (Phase 1)Study completedNCT04931147
What this trial is testing

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Who this might be right for
FibrosisInflammationIdiopathic Pulmonary Fibrosis+3 more
Redx Pharma Ltd 90
Not applicableStudy completedNCT05357352
What this trial is testing

Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis
Methodist Health System 263
Not applicableLooking for participantsNCT07658755
What this trial is testing

Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseLiver FibrosisNon-alcoholic Fatty Liver Disease NAFLD+3 more
Hospital General Universitario Gregorio Marañon 3,000
Not applicableLooking for participantsNCT04190849
What this trial is testing

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic Fatty LiverNon-alcoholic Steatohepatitis
Cambridge University Hospitals NHS Foundation Trust 2,000
Not applicableLooking for participantsNCT06308757
What this trial is testing

Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis

Who this might be right for
NASHNAFLDObesity+1 more
University of Bologna 42
Post-approval studies (Phase 4)Looking for participantsNCT05644717
What this trial is testing

Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD

Who this might be right for
Liver FatLiver FibrosisGlycemic Control+3 more
Getz Pharma 164
Not applicableStudy completedNCT03608748
What this trial is testing

Early Detection of Advanced Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseLiver Fibrosis
HaEmek Medical Center, Israel 1,000
Next Page